Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats

World Journal of Gastroenterology

Volumn 19, Issue 18, 2013, Pages 2761-2771

  Tian, Yu Feng ^a,b   He, Chih Tsueng ^c   Chen, Yu Ting ^d   Hsieh, Po Shiuan ^c,d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Fructose; Insulin secretion; Lipoic acid; Oxidative stress; Portal endotoxemia; Steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMYLASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CD68 ANTIGEN; GLUCOSE; GLUTATHIONE; INSULIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MALONALDEHYDE; SUPEROXIDE; THIOCTIC ACID; TOLL LIKE RECEPTOR 4; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; GENE EXPRESSION; HEMODYNAMIC PARAMETERS; HISTOLOGY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MALE; NONHUMAN; PANCREATITIS; RAT; SCORING SYSTEM;

EID: 84877811000     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i18.2761     Document Type: Article

References (34)

1. Marchesini G, Marzocchi R. Metabolic syndrome and NASH. Clin Liver Dis 2007; 11: 105-117 [PMID: 17544974 DOI: 10.1016/j.cld.2007.02.013]
2. Moscatiello S, Di Luzio R, Sasdelli AS, Marchesini G. Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome. Expert Opin Pharmacother 2011; 12: 2657-2672 [PMID: 22043839 DOI: 10.1517/14656566.2011.629 188]
3. Gambino R, Musso G, Cassader M. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal 2011; 15: 1325-1365 [PMID: 20969475 DOI: 10.1089/ars.2009.3058]
4. Hsieh PS. Inflammatory change of fatty liver induced by intraportal low-dose lipopolysaccharide infusion deteriorates pancreatic insulin secretion in fructose-induced insulinresistant rats. Liver Int 2008; 28: 1167-1175 [PMID: 18397237 DOI: 10.1111/j.1478-3231.2008.01714.x]
5. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997; 94: 2557-2562 [PMID: 9122234]
6. Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17: 888-895 [PMID: 11684397 DOI: 10.1016/S0899- 9007(01)00658-X]
7. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palù G, Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G518-G525 [PMID: 17023554 DOI: 10.1152/ajpgi.00024.2006]
8. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-845 [PMID: 9547102]
9. Müller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H. Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. Diabetologia 2002; 45: 805-812 [PMID: 12107724 DOI: 10.1007/ s00125-002-0829-2]
10. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acutephase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286-1292 [PMID: 9389420]
11. Hsieh PS, Chan JY, Shyu JF, Chen YT, Loh CH. Mild portal endotoxaemia induces subacute hepatic inflammation and pancreatic beta-cell dysfunction in rats. Eur J Clin Invest 2008; 38: 640-648 [PMID: 18837740 DOI: 10.1111/ j.1365-2362.2008.01991.x]
12. Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001; 121: 710-723 [PMID: 11522755 DOI: 10.1053/gast.2001.27126]
13. Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta 2009; 1790: 1149-1160 [PMID: 19664690 DOI: 10.1016/ j.bbagen.2009.07.026]
14. Bast A, Haenen GR. Lipoic acid: a multifunctional antioxidant. Biofactors 2003; 17: 207-213 [PMID: 12897442]
15. Park SJ, Seo SW, Choi OS, Park CS. Alpha-lipoic acid protects against cholecystokinin-induced acute pancreatitis in rats. World J Gastroenterol 2005; 11: 4883-4885 [PMID: 16097064]
16. Park KG, Min AK, Koh EH, Kim HS, Kim MO, Park HS, Kim YD, Yoon TS, Jang BK, Hwang JS, Kim JB, Choi HS, Park JY, Lee IK, Lee KU. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology 2008; 48: 1477-1486 [PMID: 18972440 DOI: 10.1002/hep.22496]
17. Abdin AA, El-Hamid MA, El-Seoud SH, Balaha MF. Effect of pentoxifylline and/or alpha lipoic acid on experimentally induced acute pancreatitis. Eur J Pharmacol 2010; 643: 289-296 [PMID: 20599924 DOI: 10.1016/j.ejphar.2010.06.020]
18. Bustamante J, Lodge JK, Marcocci L, Tritschler HJ, Packer L, Rihn BH. Alpha-lipoic acid in liver metabolism and disease. Free Radic Biol Med 1998; 24: 1023-1039 [PMID: 9607614 DOI: 10.1016/S0891-5849(97)00371-7]
19. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56: 1761-1772 [PMID: 17456850 DOI: 10.2337/db06-1491]
20. Curat CA, Miranville A, Sengenès C, Diehl M, Tonus C, Busse R, Bouloumié A. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004; 53: 1285-1292 [PMID: 15111498 DOI: 10.2337/diabetes.53.5.1285]
21. Cremer DR, Rabeler R, Roberts A, Lynch B. Long-term safety of alpha-lipoic acid (ALA) consumption: A 2-year study. Regul Toxicol Pharmacol 2006; 46: 193-201 [PMID: 16899332 DOI: 10.1016/j.yrtph.2006.06.003]
22. Cremer DR, Rabeler R, Roberts A, Lynch B. Safety evaluation of alpha-lipoic acid (ALA). Regul Toxicol Pharmacol 2006; 46: 29-41 [PMID: 16904799 DOI: 10.1016/j.yrtph.2006.06.004]
23. Wagoner B, Hausman DB, Harris RB. Direct and indirect effects of leptin on preadipocyte proliferation and differentiation. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1557-R1564 [PMID: 16424081 DOI: 10.1152/ajpregu. 00860.2005]
24. Marques BG, Hausman DB, Latimer AM, Kras KM, Grossman BM, Martin RJ. Insulin-like growth factor I mediates high-fat diet-induced adipogenesis in Osborne-Mendel rats. Am J Physiol Regul Integr Comp Physiol 2000; 278: R654-R662 [PMID: 10712285]
25. Ghanim H, Garg R, Aljada A, Mohanty P, Kumbkarni Y, Assian E, Hamouda W, Dandona P. Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab 2001; 86: 1306-1312 [PMID: 11238525 DOI: 10.1210/jc.86.3.1306]
26. Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, Balas B, Gastaldelli A, Tio F, Pulcini J, Berria R, Ma JZ, Dwivedi S, Havranek R, Fincke C, DeFronzo R, Bannayan GA, Schenker S, Cusi K. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med 2006; 355: 2297-2307 [PMID: 17135584 DOI: 10.1056/NEJMoa060326]
27. Packer L, Witt EH, Tritschler HJ. alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-250 [PMID: 7649494 DOI: 10.1016/0891-5849(95)00017-R]
28. Lin Y, Yu LX, Yan HX, Yang W, Tang L, Zhang HL, Liu Q, Zou SS, He YQ, Wang C, Wu MC, Wang HY. Gut-derived lipopolysaccharide promotes T-cell-mediated hepatitis in mice through Toll-like receptor 4. Cancer Prev Res (Phila) 2012; 5: 1090-1102 [PMID: 22617167 DOI: 10.1158/1940-6207. CAPR-11-0364]
29. Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 2009; 50: 1094-1104 [PMID: 19637282 DOI: 10.1002/hep.23122]
30. Inokuchi S, Tsukamoto H, Park E, Liu ZX, Brenner DA, Seki E. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res 2011; 35: 1509-1518 [PMID: 21463341 DOI: 10.1111/j.1530-0277.2011.01487.x]
31. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025 [PMID: 17053832 DOI: 10.1172/JCI28898]
32. Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A. HMGB1: endogenous danger signaling. Mol Med 2008; 14: 476-484 [PMID: 18431461 DOI: 10.2119/2008-00034.Klune]
33. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48: 322-335 [PMID: 18506843 DOI: 10.1002/hep.22306]
34. Lee BW, Kwon SJ, Chae HY, Kang JG, Kim CS, Lee SJ, Yoo HJ, Kim JH, Park KS, Ihm SH. Dose-related cytoprotective effect of alpha-lipoic acid on hydrogen peroxide-induced oxidative stress to pancreatic beta cells. Free Radic Res 2009; 43: 68-77 [PMID: 19358002 DOI: 10.1080/10715760802590400]